Lena Markov chose a diner on the edge of Riverbend’s industrial district, a place called Halcyon’s that served bitter coffee and eggs at any hour. Catherine arrived early, parking her wheelchair at a corner booth with a clear sightline to both exits. The tremor in her left hand was worse tonight, a reminder that her body kept its own score of stress. She ordered tea and waited, the steam curling into the fluorescent light while a radio behind the counter murmured news of the Attorney General’s motion to quash her discovery request.
At precisely eleven o’clock, a woman slid into the opposite seat. She was younger than Catherine expected, mid-thirties, with dark hair pulled back in a hasty ponytail and eyes that had the hollowed look of someone who hadn’t slept in days. She wore a nondescript gray coat and carried a tablet in a battered leather case. “You’re Aldaine,” she said. It wasn’t a question.
“And you’re Markov,” Catherine replied. “Your note said you designed the algorithm. Start there.”
Lena’s fingers tightened around her coffee cup. She spoke in a low, rapid voice, as if the words had been dammed up for months. She explained that she had joined the Federal Bureau of Corrections six years earlier, fresh out of a graduate program in computational sociology at Meridian University. Her specialty was predictive modeling for institutional populations, developing software that could forecast inmate medical needs, staffing requirements, and budget allocations. The work had seemed noble at the time: using data to make the correctional system more humane and efficient.
Then, four years ago, the Bureau had been approached by the Social Security Administration. The SSA was under congressional pressure to reduce its disability rolls, and it had developed an algorithmic assessment tool called the Residual Functional Capacity Evaluator, or RFCE. The tool analyzed medical records, physician opinions, and occupational data to determine whether a claimant could perform sedentary work. Catherine knew it intimately; she had spent years litigating against its predecessor, arguing that it systematically devalued treating physician opinions and denied benefits to people who were genuinely disabled. Her victory in Voss v. SSA had forced the agency to revise the algorithm, incorporating more robust procedural safeguards. The RFCE was the supposedly reformed version.
“I helped integrate the RFCE into the Bureau’s intake system,” Lena said, her voice trembling slightly. “The idea was that inmates entering the federal prison system often had prior disability claims. By cross-referencing those records, we could better allocate medical resources. That was the official justification. But about eighteen months ago, I noticed an anomaly.”
She pulled up a set of charts on her tablet, angling the screen so Catherine could see. The data showed a subset of inmates who had been denied SSA benefits, all of whom shared a particular neurological marker: a variant of the SNCA gene associated with heightened synaptic plasticity. The marker was rare, occurring in less than half a percent of the population, but it appeared in nearly every inmate who had been transferred to Carmine Asylum’s Cypress Ward over the past three years.
“I didn’t flag this marker,” Lena said. “It wasn’t in my original code. Someone added it after the fact, a patch that bypassed the usual audit trails. The patch originated from a server inside Carmine Asylum itself.”
Catherine absorbed the information in silence. The pieces were assembling into a monstrous shape. The SSA’s algorithm had not merely been corrected; it had been weaponized. A denied disability claim was not the end of a person’s interaction with the state. It was, for a specific genetic subset, the beginning of a pipeline that terminated in a locked ward where their brains were harvested.
“Who authorized the patch?” Catherine asked.
“I don’t know,” Lena admitted. “The access logs were wiped. But the patch’s architecture is consistent with code written by a contractor called Cerebra Solutions, which is a shell company owned by NeuVault Industries. They’re the ones running the Cypress Ward research under a contract with the Albion Department of Corrections.”
Catherine set down her teacup. “You’ve given me the link between the SSA denial and the prison transfer. But to prove this in court, I need the contract itself, the protocols, the names of the people who made the decisions. Can you get those?”
Lena shook her head. “The Cypress Ward’s servers are air-gapped from the main prison network. I can’t access them remotely. But there’s another way. Every six months, the facility submits a compliance report to the Administrative Law Division of the Department of Corrections, certifying that all medical protocols meet statutory standards. The hearing is public, but nobody ever attends. It’s a rubber stamp.”
“Not this time,” Catherine said.
The Administrative Law Division occupied a nondescript building in downtown Riverbend, its corridors lined with framed photographs of past commissioners and motivational posters extolling the virtues of efficiency. The hearing room was small, furnished with a laminate table, ergonomic chairs, and a recording device that blinked with a steady green light. The Administrative Law Judge assigned to the proceeding was a man named Gerald Pemberton, a career bureaucrat with a placid expression and an air of bureaucratic lethargy.
Seated opposite Catherine was Dr. Aldric Vance, Chief Medical Officer of Carmine Asylum. He was a tall man with silvered hair and expensive spectacles, wearing a lab coat over a tailored suit. Next to him sat a lawyer from the Department of Corrections, a woman who introduced herself as Ms. Threlfall. The hearing had been convened under the Administrative Procedure Act, specifically under a provision that allowed any citizen to petition for review of agency compliance records. Catherine had filed a motion alleging that Carmine Asylum had failed to adhere to the Neuro-Rights Preservation Act and that the facility’s medical protocols required independent scrutiny. Judge Pemberton had granted the hearing with visible reluctance, likely hoping it would be brief and uneventful.
Catherine began with procedural questions, establishing the chain of authority. Dr. Vance answered smoothly, describing the Cypress Ward as a specialized medical unit for inmates with complex neurological conditions. He cited recidivism statistics and rehabilitation outcomes, deploying the language of therapeutic progress with practiced ease. Catherine let him talk, building a record of his own words.
Then she introduced the cross-reference data Lena had provided. “Dr. Vance, is it true that every inmate currently housed in the Cypress Ward was previously denied Social Security disability benefits?”
Vance’s expression flickered, a momentary crack in his composure. “I’m not familiar with the specifics of each inmate’s prior benefit history.”
“Then let me refresh your recollection.” Catherine pushed a document across the table. “This is a roster of the seventeen inmates currently in the Cypress Ward. Each of them has a prior denial from the Social Security Administration. Each denial was based on an algorithmic assessment that flagged them as having residual functional capacity despite their medical conditions. And each of them, Dr. Vance, carries the SNCA gene variant associated with heightened synaptic plasticity. Is that a coincidence?”
Threlfall interjected, objecting that the question was outside the scope of the compliance review. Judge Pemberton hesitated, but Catherine pressed forward. “Your Honor, the scope of this review is whether Carmine Asylum is complying with the law. If the facility is selecting inmates for a specialized medical unit based on genetic markers and prior benefit denials, that raises serious questions about informed consent and the voluntariness of any treatment being administered.”
Pemberton adjusted his glasses. “Dr. Vance, you may answer.”
Vance cleared his throat. “Carmine Asylum does conduct voluntary medical research in partnership with NeuVault Industries. The research is aimed at developing therapeutic interventions for recidivism reduction. Inmates who participate do so with full informed consent, and the genetic marker you reference is merely a screening criterion to identify suitable candidates for neurological therapies. There is nothing illegal about that.”
“What is the name of the research project?” Catherine asked.
“It is called the Synaptic Rehabilitation Initiative,” Vance said.
Catherine had anticipated the deflection. Lena had already briefed her on the internal nomenclature. “And is the Synaptic Rehabilitation Initiative the same program that your internal documents refer to as Project Synapse?”
Silence. Threlfall leaned over and whispered something to Vance. The doctor’s face tightened. “I am not aware of any project by that name.”
Catherine produced another document, this one a redacted internal email from Carmine Asylum’s server, recovered by Lena from a backup archive before the Cypress Ward went air-gapped. The email was addressed to Dr. Vance and referenced “Project Synapse extraction quotas.” The word “Synapse” was partially redacted, but the context was unmistakable.
“This email was sent by a senior researcher at NeuVault Industries, Dr. Yvonne Calder,” Catherine said. “She references extraction quotas for Project Synapse. Would you like to revise your previous answer?”
Threlfall immediately moved to strike the email as unauthenticated and outside the scope of the hearing. Judge Pemberton, visibly uncomfortable, sustained the objection but noted that the document would be retained for the record under seal. Catherine accepted the ruling, knowing that the damage had been done. The name Project Synapse was now part of the official transcript. Whatever happened next, the public record would contain a reference to a project that did not officially exist.
The hearing concluded shortly afterward. Catherine gathered her files and wheeled herself into the corridor, where Lena was waiting in a small alcove near the elevators. “How did it go?” Lena asked.
“Vance lied on the record,” Catherine said. “Which means he’s afraid of what we might find. The judge sealed the email, but the transcript will show the name. That’s a foothold.”
Lena nodded, but her expression remained troubled. “There’s something else. While you were in the hearing, I accessed the Bureau’s real-time monitoring dashboard. Someone ran a query on your case history this morning, pulling every motion you’ve ever filed in federal court. The query came from an IP address registered to the Office of the Attorney General.”
Catherine felt a chill that had nothing to do with the building’s air conditioning. The government was not just defending a lawsuit; it was studying her, mapping her litigation patterns, looking for vulnerabilities. “We need to accelerate. Can you pull the contract between Carmine Asylum and NeuVault Industries?”
“I can try,” Lena said. “But I’ll need to get physical access to a terminal inside the Department of Corrections headquarters. They’ve locked down remote access since the Expositor article broke. And there’s something else you should see.”
She handed Catherine a tablet displaying a list of names. It was a roster of inmates who had been transferred to the Cypress Ward over the past five years, compiled from fragmentary data Lena had extracted before the servers went dark. Next to each name was a status indicator. Some said “Active.” Others said “Completed.” And a third category said “Uploaded.”
“What does ‘Uploaded’ mean?” Catherine asked, though she already suspected the answer.
“I don’t know for certain,” Lena said. “But the inmates marked ‘Uploaded’ have no further medical entries after a certain date. No treatment records, no prescriptions, no cell transfers. It’s as if they ceased to exist as biological entities. But their inmate files were never closed.”
Catherine scrolled through the list. There were twenty-three names marked “Uploaded.” Elias Voss was the most recent. She recognized two others: men she had represented briefly in civil matters years earlier, both with denied disability claims, both convicted of violent offenses, both transferred to Carmine Asylum and never heard from again.
“They were erased,” Catherine murmured.
“Not erased,” Lena corrected. “Stored. The neural maps are somewhere on NeuVault’s servers. They’re not dead, exactly. They’ve been converted into data.”
The two women stood in the empty corridor, the hum of the fluorescent lights filling the silence. Catherine thought of the legal argument she had made to Judge Vasquez: that neural imprints were a form of property, recoverable by an inmate’s estate. It was a novel theory, but it assumed that the imprints were distinct, discrete entities. What if they were not? What if Project Synapse was aggregating them, layering one consciousness over another to build something larger, a composite mind or a predictive model of criminal behavior? The implications were terrifying.
“Lena, I need you to get that contract,” Catherine said. “And I need to know who runs NeuVault Industries. Not the shell companies, the actual board of directors. If this is a government project, there’s a funding trail. Follow the money.”
Lena nodded. “There’s a gala tonight at the Albion Securities Exchange, a fundraiser for the Prison Reform Initiative. NeuVault is a sponsor. I can get in as a caterer if I move fast.”
“Be careful,” Catherine said. “They’re already watching me. They’ll be watching anyone connected to me.”
Lena managed a thin smile. “I’ve been invisible my whole career. I can be invisible for one more night.”
The gala was held in the marble atrium of the Albion Securities Exchange, a soaring space filled with potted palms, champagne fountains, and men in tailored suits who spoke the language of investment portfolios and correctional efficiency. Lena, dressed in a borrowed caterer’s uniform, moved through the crowd with a tray of canapés, a discreet earpiece linking her to Catherine, who waited in a van three blocks away.
The keynote speaker was a woman named Marguerite Ashford, Chair of the Albion Prison Reform Initiative and a former senator. She spoke eloquently about the moral imperative of rehabilitation, the need to treat incarceration as an opportunity for transformation rather than mere punishment. The audience applauded warmly. Lena scanned the room, identifying the NeuVault Industries table near the dais.
She recognized two faces from her research: Dr. Yvonne Calder, the researcher who had authored the Project Synapse email, and a man named Julian Cross, NeuVault’s Chief Technology Officer. Cross was young, mid-forties, with the confident bearing of someone who had never been told no. He was deep in conversation with a man Lena did not immediately recognize, a gaunt figure in a dark suit with an unmistakable presence: Warden Alistair Thorne of Carmine Asylum.
Lena angled her tray and moved closer. She activated the microphone on her earpiece, transmitting the conversation to Catherine. The audio was fragmentary, muffled by the ambient noise of the gala, but certain phrases cut through.
“...extraction quota met for this quarter,” Thorne was saying. “The upload integrity is stable at ninety-four percent.”
“The investors want a demonstration,” Cross replied. “Something tangible. A memory retrieval, a behavioral simulation. They need to see that the product works before they commit to the next funding round.”
“The product,” Thorne said, “is not a parlor trick. It’s the most sophisticated criminal-predictive engine ever developed. We’ve mapped the neural signatures of two dozen violent offenders. The algorithm can identify pre-crime behavioral patterns with eighty-seven percent accuracy.”
Lena’s hand trembled slightly, rattling the glasses on her tray. She steadied herself and moved on before anyone noticed.
Back in the van, Catherine listened to the recording with a growing sense of dread. Pre-crime prediction. Neural signature mapping. The language was corporate, sanitized, stripped of any acknowledgment that the raw material of this enterprise was human beings. The progress Thorne and Cross were celebrating was built on the systematic destruction of lives already deemed disposable by the state.
“They’re selling a product,” Catherine said when Lena returned to the van. “A predictive model built from the minds of the people we were supposed to be protecting.”
Lena slumped into the passenger seat, her borrowed uniform stained with champagne. “There’s more. While I was inside, I managed to swipe a guest list from the registration table. The board of NeuVault Industries includes three former commissioners of the Social Security Administration. They’re the ones who approved the original RFCE algorithm.”
The revelation landed with the weight of a physical blow. The same people who had designed the disability determination process, the people who had fought Catherine in court, the people whose system she had believed she had reformed, were now profiting from its darker application. The algorithm had not been corrupted by rogue actors; it had been built, from the beginning, with a dual purpose. The denial of benefits was not merely callous bureaucracy. It was a sorting mechanism, a way of identifying subjects for a more profitable form of institutionalization.
Catherine stared at the glittering facade of the Albion Securities Exchange through the van’s tinted windows. “We need to get this evidence to Judge Vasquez before they realize we have it.”
“And then what?” Lena asked. “Even if the court orders them to release the neural data, NeuVault will claim it’s proprietary technology. They’ll tie us up in litigation for years.”
“Then we don’t play by their rules,” Catherine said. “There’s a provision in the Administrative Procedure Act that allows for emergency injunctive relief if an agency action threatens irreparable harm. I can argue that the continued operation of Project Synapse constitutes an ongoing violation of the Neuro-Rights Preservation Act. If I can get Judge Vasquez to appoint a special master to take custody of the servers, we can freeze the data before they destroy it.”
“You’re betting on a judge who hasn’t even ruled on your first motion yet.”
“I’m betting on the law,” Catherine said. “It’s the only thing they can’t buy.”
But as the van pulled away from the curb, neither woman noticed the black sedan that followed at a careful distance, its headlights dark, its driver speaking quietly into a encrypted phone. The watchers had found Lena Markov, and they were no longer content to simply observe.


No comments yet. Be the first to comment!